Protein kinase C peptides for use in withdrawal

Details Protein kinase C peptides for use in withdrawal Protein kinase C peptides for use in withdrawal

2005-08-23

2005-08-23

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S016700, C514S017400, C530S300000, C530S328000, C530S329000

Reexamination Certificate

active

06933275

ABSTRACT:
A method for managing withdrawal from an addictive substance is described. The method involves administering one or more peptides having specific activity for the ε and/or γ isozyme of protein kinase C (PKC). The peptide(s) can be administered prior to, concurrent with, or subsequent to administration of the addictive substance. Also described is a kit having at least one container containing a peptide having isozyme-specific activity for εPKC or γPKC and instructions for use.

REFERENCES:
patent: 5783405 (1998-07-01), Mochly-Rosen et al.
patent: 6165977 (2000-12-01), Mochly-Rosen
patent: 6376467 (2002-04-01), Messing et al.
patent: 2003/0223981 (2003-12-01), Mochly-Rosen et al.
patent: WO 00/01805 (2000-01-01), None
patent: WO 03/089457 (2003-10-01), None
Aley, K.O., et al.,The Journal of Neuroscience, 20(12):4680-4685, (2000).
Dina, O.A., et al.,The Journal of Neuroscience 20(22):8614-8619, (2000).
Narita, M., et al.,The Journal of Neuroscience 21(11): 3715-3720, (2001).

Affiliated with

Also associated with

Rating

Protein kinase C peptides for use in withdrawal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein kinase C peptides for use in withdrawal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase C peptides for use in withdrawal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3447679